KERYX BIOPHARMACEUTICALS INC Proceeds from Notes Payable
KERYX BIOPHARMACEUTICALS INC reported Proceeds from Notes Payable of $15.00 million for the 9-month period ending 2018-09-30, per its 10-Q filed 2018-11-08.
Discontinued › Cash Flow › Financing Activities
us-gaap:ProceedsFromNotesPayable · last filed 2018-11-08
- 2018-09-30: Proceeds from Notes Payable 9 month $15.00M.
- 2017-09-30: Proceeds from Notes Payable 9 month $0.00.
| Period end | Proceeds from Notes Payable 9 month |
|---|---|
| 2018-09-30 | $15.00M 10-Q · filed 2018-11-08 |
| 2017-09-30 | $0.00 10-Q · filed 2018-11-08 |